Video: Pfizer’s Criminal Record. Largest Medical “Fraudulent Marketing” Case in US History

Region:

Pfizer “Largest Health Care Fraud” 2009

Déjà Vu: Flash Forward to 2020-2021

How on earth could you trust a Big Pharma vaccine conglomerate which pleaded guilty to criminal charges by the US Department of Justice including “fraudulent marketing” and “felony violation of the Food, Drug and Cosmetic Act”?

The 2020-2021 mRNA vaccine violations far surpass the health care fraud committed by Pfizer Inc in 2009.

“Fraudulent marketing” is an understatement: The mRNA vaccine announced by Pfizer – BioNTech is based on an experimental gene editing mRNA technology which has a bearing on the human genome.  The standard animal lab tests using mice or ferrets were not conducted.  Pfizer “went straight to human “guinea pigs.”

M. Ch,   Global Research Editor, May 15, 2021

VIDEO. US Department of Justice (DOJ) Statement

$2.3 Billion  Medical Fraud settlement with Pfizer


Comment on Global Research Articles on our Facebook page

Become a Member of Global Research


Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]